Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-01-26

FDA Approved: FOSFOMYCIN TROMETHAMINE — Original Application (Cipla USA Inc.)

View source ↗

Summary

FDA approved the original application for fosfomycin tromethamine, a generic antibiotic, manufactured by Cipla USA Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FOSFOMYCIN TROMETHAMINE (FOSFOMYCIN TROMETHAMINE)

Snippet

ORIG AP for FOSFOMYCIN TROMETHAMINE (FOSFOMYCIN TROMETHAMINE)